Loading...
JINS HOLDINGS Inc.
JNDOF•PNK
Healthcare
Medical - Instruments & Supplies
$22.75
$0.00(0.00%)
JINS HOLDINGS Inc. (JNDOF) Financial Performance & Income Statement Overview
Review JINS HOLDINGS Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.29%
↑ 13.29%
Operating Income Growth
61.69%
↑ 61.69%
Net Income Growth
165.10%
↑ 165.10%
Operating Cash Flow Growth
81.52%
↑ 81.52%
Operating Margin
9.44%
↑ 9.44%
Gross Margin
76.80%
↑ 76.80%
Net Profit Margin
5.63%
↑ 5.63%
ROE
19.89%
↑ 19.89%
ROIC
27.62%
↑ 27.62%
JINS HOLDINGS Inc. (JNDOF) Income Statement & Financial Overview
Review JINS HOLDINGS Inc.'s (JNDOF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $23.78B | $21.06B | $23.84B | $21.14B |
| Cost of Revenue | $5.29B | $4.45B | $6.38B | $5.29B |
| Gross Profit | $18.49B | $16.61B | $17.46B | $15.86B |
| Gross Profit Ratio | $0.78 | $0.79 | $0.73 | $0.75 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $6.00M |
| SG&A Expenses | $15.34B | $14.60B | $14.68B | $13.35B |
| Operating Expenses | $15.34B | $14.60B | $14.68B | $13.36B |
| Total Costs & Expenses | $20.62B | $19.05B | $21.06B | $18.65B |
| Interest Income | $12.00M | $0.00 | $5.00M | $4.00M |
| Interest Expense | $58.00M | $0.00 | $34.00M | $31.00M |
| Depreciation & Amortization | $710.00M | $688.00M | $787.00M | $723.00M |
| EBITDA | $4.38B | $2.69B | $2.54B | $2.48B |
| EBITDA Ratio | $0.18 | $0.13 | $0.11 | $0.12 |
| Operating Income | $3.15B | $2.003B | $2.78B | $2.50B |
| Operating Income Ratio | $0.13 | $0.10 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | $460.00M | -$60.00M | -$543.00M | -$49.00M |
| Income Before Tax | $3.61B | $1.94B | $2.23B | $2.45B |
| Income Before Tax Ratio | $0.15 | $0.09 | $0.09 | $0.12 |
| Income Tax Expense | $1.14B | $626.00M | $736.00M | $829.00M |
| Net Income | $2.47B | $1.32B | $1.50B | $1.62B |
| Net Income Ratio | $0.10 | $0.06 | $0.06 | $0.08 |
| EPS | $105.74 | $53.85 | $64.14 | $69.28 |
| Diluted EPS | $105.74 | $53.85 | $61.28 | $66.32 |
| Weighted Avg Shares Outstanding | $23.34M | $24.46M | $23.34M | $23.34M |
| Weighted Avg Shares Outstanding (Diluted) | $23.34M | $24.46M | $24.43M | $24.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan